Current understanding of delayed anticonvulsant hypersensitivity reactions

Area of Science:

• Pharmacology
• Immunology
• Toxicology

Background:

• Hypersensitivity syndrome (HSS) reactions are severe idiosyncratic drug reactions, frequently associated with antiepileptic drugs (AEDs).
• HSS involves T-cell-mediated inflammatory injuries in tissues rich in cytochrome oxidases, indicating a xenobiotic defense system derangement.
• These reactions manifest in barrier tissues such as skin, mucosa, liver, and lungs.

Purpose of the Study:

• To review the classification of anticonvulsant-induced Hypersensitivity Syndrome (HSS).
• To elucidate the potential mechanisms underlying HSS reactions caused by antiepileptic drugs.
• To provide insights into the genetic and molecular basis of these severe adverse drug reactions.

Main Methods:

• Literature review focusing on Hypersensitivity Syndrome (HSS) and antiepileptic drugs (AEDs).
• Analysis of proposed mechanisms involving drug metabolites, T-cell activation, and cytokine production.
• Examination of genetic susceptibility factors and major histocompatibility complex (MHC)-dependent and independent pathways.

Main Results:

• Anticonvulsant Hypersensitivity Syndrome (HSS) mechanisms involve genetic predisposition.
• Accumulation of antiepileptic drugs (AEDs) and their oxidized metabolites triggers T-cell activation.
• Major histocompatibility complex (MHC) and non-MHC pathways contribute to clonal T-cell activation and subsequent inflammation.

Conclusions:

• Anticonvulsant Hypersensitivity Syndrome (HSS) is a complex T-cell-mediated reaction.
• Genetic factors play a significant role in the development of HSS.
• Further research into the precise mechanisms is needed to improve the management of these severe drug reactions.